Literature DB >> 28008659

BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.

Cristina Berastegui1, Susana Gómez-Ollés1,2, Sara Sánchez-Vidaurre1, Mario Culebras1, Victor Monforte1,2, Manuel López-Meseguer1, Carlos Bravo1,2, Maria-Antonia Ramon1, Laura Romero3, Joan Sole3, Maria-Jesus Cruz1,2, Antonio Román1,2.   

Abstract

The long-term success of lung transplantation (LT) is limited by chronic lung allograft dysfunction (CLAD). Different phenotypes of CLAD have been described, such as bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS). The purpose of this study was to investigate the levels of cytokines and chemokines in bronchoalveolar lavage fluid (BALF) as markers of these CLAD phenotypes. BALF was collected from 51 recipients who underwent (bilateral and unilateral) LT. The study population was divided into three groups: stable (ST), BOS, and RAS. Levels of interleukin (IL)-4, IL-5, IL-6, IL-10, IL-13, tumor necrosis factor alpha (TNF-α), interferon-gamma (IFN-γ), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were measured using the multiplex technology. BALF neutrophilia medians were higher in BOS (38%) and RAS (30%) than in ST (8%) (P=.008; P=.012). Regarding BALF cytokines, BOS and RAS patients showed higher levels of INF-γ than ST (P=.02; P=.008). Only IL-5 presented significant differences between BOS and RAS (P=.001). BALF neutrophilia is as a marker for both CLAD phenotypes, BOS and RAS, and IL-5 seems to be a potential biomarker for the RAS phenotype.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BOS; RAS; bronchoalveolar lavage; chronic rejection; cytokines

Mesh:

Substances:

Year:  2017        PMID: 28008659     DOI: 10.1111/ctr.12898

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  11 in total

1.  SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.

Authors:  Kumi Mesaki; Masaomi Yamane; Seiichiro Sugimoto; Masayoshi Fujisawa; Teizo Yoshimura; Takeshi Kurosaki; Shinji Otani; Shinichiro Miyoshi; Takahiro Oto; Akihiro Matsukawa; Shinichi Toyooka
Journal:  Surg Today       Date:  2019-01-07       Impact factor: 2.549

Review 2.  Challenges in the use of highly effective modulator treatment for cystic fibrosis.

Authors:  Kathleen J Ramos; Joseph M Pilewski; Jennifer L Taylor-Cousar
Journal:  J Cyst Fibros       Date:  2021-01-30       Impact factor: 5.482

3.  Bronchoalveolar lavage cytokines are of minor value to diagnose complications following lung transplantation.

Authors:  Nicole E Speck; Elisabeth Probst-Müller; Sarah R Haile; Christian Benden; Malcolm Kohler; Lars C Huber; Cécile A Robinson
Journal:  Cytokine       Date:  2019-08-07       Impact factor: 3.861

4.  Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.

Authors:  Joshua Y C Yang; Stijn E Verleden; Arya Zarinsefat; Bart M Vanaudenaerde; Robin Vos; Geert M Verleden; Reuben D Sarwal; Tara K Sigdel; Juliane M Liberto; Izabella Damm; Drew Watson; Minnie M Sarwal
Journal:  J Clin Med       Date:  2019-02-13       Impact factor: 4.241

5.  Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.

Authors:  Cristina Berastegui; Susana Gómez-Ollés; Alberto Mendoza-Valderrey; Thais Pereira-Veiga; Mario Culebras; Victor Monforte; Berta Saez; Manuel López-Meseguer; Helena Sintes-Permanyer; Victoria Ruiz de Miguel; Carlos Bravo; Judit Sacanell; María-Antonia Ramon; Laura Romero; María Deu; Antonio Román
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

Review 6.  Novel approaches for long-term lung transplant survival.

Authors:  Cynthia L Miller; Jane M O; James S Allan; Joren C Madsen
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

Review 7.  [Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].

Authors:  Sijia Yang; Abudumailamu Abuduwufuer; Wang Lv; Feichao Bao; Jian Hu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-06-20

Review 8.  Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?

Authors:  Masaaki Sato
Journal:  Ann Transl Med       Date:  2020-03

9.  Mir-27a-3p attenuates bronchiolitis obliterans in vivo via the regulation of dendritic cells' maturation and the suppression of myofibroblasts' differentiation.

Authors:  Ming Dong; Xin Wang; Tong L; Jing Wang; Yunwei Yang; Yi Liu; Yaqing Jing; Honglin Zhao; Jun Chen
Journal:  Clin Transl Med       Date:  2020-08

10.  The Role of Galectins in Chronic Lung Allograft Dysfunction.

Authors:  Miriana d'Alessandro; Laura Bergantini; Antonella Fossi; Elda De Vita; Felice Perillo; Luca Luzzi; Piero Paladini; Piersante Sestini; Paola Rottoli; Elena Bargagli; David Bennett
Journal:  Lung       Date:  2021-05-03       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.